607 related articles for article (PubMed ID: 30344418)
1. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
2. HCV in Egypt, prevention, treatment and key barriers to elimination.
El Kassas M; Elbaz T; Elsharkawy A; Omar H; Esmat G
Expert Rev Anti Infect Ther; 2018 Apr; 16(4):345-350. PubMed ID: 29506418
[TBL] [Abstract][Full Text] [Related]
3. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
4. An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.
El Kassas M; Alboraie M; Omran D; Salaheldin M; Wifi MN; ElBadry M; El Tahan A; Ezzat S; Moaz E; Farid AM; Omar H; Abouelkhair M; Afify S; Elsaeed K; Shazly Y; Doss W; Esmat G
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1265-1272. PubMed ID: 29757684
[TBL] [Abstract][Full Text] [Related]
5. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
[TBL] [Abstract][Full Text] [Related]
7. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model.
Heffernan A; Cooke GS; Nayagam S; Thursz M; Hallett TB
Lancet; 2019 Mar; 393(10178):1319-1329. PubMed ID: 30704789
[TBL] [Abstract][Full Text] [Related]
8. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
9. Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
van Dijk M; Kracht PAM; Arends JE; Blokzijl H; Burger DM; van Erpecum KJ; van Hoek B; de Knegt RJ; Posthouwer D; Ramsoekh D; Rijnders BJA; Schinkel J; Willemse SB; van der Valk M; Drenth JPH; Behalf Of The HepNed Study Group O
Neth J Med; 2019 May; 77(4):131-138. PubMed ID: 31502544
[TBL] [Abstract][Full Text] [Related]
10. Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt.
Esmat G; Elbaz T; Elsharkawy A; Abdullah M; El Kassas M
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):637-642. PubMed ID: 32302245
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis B and C in children.
El-Shabrawi M; Hassanin F
Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
[TBL] [Abstract][Full Text] [Related]
12. Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.
Krauth C; Rossol S; Ortsäter G; Kautz A; Krüger K; Herder B; Stahmeyer JT
BMC Infect Dis; 2019 Dec; 19(1):1019. PubMed ID: 31791253
[TBL] [Abstract][Full Text] [Related]
13. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.
El-Akel W; El-Sayed MH; El Kassas M; El-Serafy M; Khairy M; Elsaeed K; Kabil K; Hassany M; Shawky A; Yosry A; Shaker MK; ElShazly Y; Waked I; Esmat G; Doss W
J Viral Hepat; 2017 Apr; 24(4):262-267. PubMed ID: 28145032
[TBL] [Abstract][Full Text] [Related]
14. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
[TBL] [Abstract][Full Text] [Related]
15. Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.
Elsharkawy A; El-Raziky M; El-Akel W; El-Saeed K; Eletreby R; Hassany M; El-Sayed MH; Kabil K; Ismail SA; El-Serafy M; Abdelaziz AO; Shaker MK; Yosry A; Doss W; El-Shazly Y; Esmat G; Waked I
J Hepatol; 2018 Apr; 68(4):691-698. PubMed ID: 29223371
[TBL] [Abstract][Full Text] [Related]
16. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
17. REtrieval And cure of Chronic Hepatitis C (REACH): Results of micro-elimination in the Utrecht province.
Kracht PAM; Arends JE; van Erpecum KJ; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Wensing AMJ; Deege MPH; Dimmendaal M; Stadhouders PHGM; Friederich PW; Verhagen MAMT; Boland GJ; Hoepelman AIM
Liver Int; 2019 Mar; 39(3):455-462. PubMed ID: 30204289
[TBL] [Abstract][Full Text] [Related]
18. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
Asselah T; Bourlière M
Gastroenterol Clin North Am; 2015 Dec; 44(4):859-70. PubMed ID: 26600224
[TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2021 Feb; 74(2):303-311. PubMed ID: 32931878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
